Cronos Group (CRON) – Globe Newswire
-
Cannabis Market Flourishes Amid Global Legalization, Driving Concerns About Road Safety
-
Cronos Launches Lord Jones® Chocolate Fusions
-
Cronos Group Inc. to Speak at the 36th Annual Roth Conference
-
Cronos Group Reports 2023 Fourth Quarter and Full-Year Results¹
-
Cronos Group Inc. to Hold 2023 Fourth Quarter and Full-Year Earnings Conference Call on February 29, 2024
-
Cronos’ Spinach® Brand Ends 2023 as the Number One Flower Brand in Canada1
-
Hemp-CBD Market Demand Gaining Momentum While Projected to Reach $16 Billion By 2025
-
Cronos Enters Australian Cannabis Market
-
Premium Cannabis Brand Lord Jones® Launches Live Resin Vapes
-
Cronos Group Inc. enters into agreement for the sale-leaseback of its Stayner, Ontario facility
-
Cronos Group Reports 2023 Third Quarter Results
-
Lord Jones®, an Award-Winning Premium Cannabis Brand, Launches with Ice Water Hash Fusions Pre-Rolls in Canada
-
Cronos Unveils its New THCV Products: Spinach FEELZ™ Full Tilt
-
Cronos Group Inc. to Hold 2023 Third Quarter Earnings Conference Call on November 8, 2023
-
Cronos brand Spinach® Wins Best Pre-Roll at Grow Up Awards
-
Cronos launches leading medical brand PEACE NATURALS® in Germany
-
Cronos Group Reports 2023 Second Quarter Results
-
Cronos Group Inc. to Hold 2023 Second Quarter Earnings Conference Call on August 8, 2023
-
Cronos Group Inc. confirms receipt of unsolicited indications of interest
-
Cronos Group Inc. Announces Results of 2023 Annual Meeting of Shareholders
-
Cronos Group Announces Streamlined Operating Structure to Improve Cash Flow
-
Cronos Group Inc. to Speak at Bernstein's 39th Annual Strategic Decisions Conference
-
Cronos Group Inc. to Speak at Bernstein's 39th Annual Strategic Decisions Conference
-
Cronos Group Inc. to Speak at the Canaccord Genuity 7th Annual Global Cannabis Conference
-
Cronos Group Reports 2023 First Quarter Results
-
Cronos Group Inc. to Hold Virtual 2023 Annual Meeting of Shareholders
-
Cronos Group Inc. to Hold Virtual 2023 Annual Meeting of Shareholders
-
Cronos Group Inc. to Hold 2023 First Quarter Earnings Conference Call on May 9, 2023
-
Cronos Group Inc. to Hold 2023 First Quarter Earnings Conference Call on May 9, 2023
-
Cronos Group Releases Cannabinoid Life Cycle Study Highlighting its Sustainable Fermentation Practices
-
Cronos Group Releases Cannabinoid Life Cycle Study Highlighting its Sustainable Fermentation Practices
-
Cronos Bolsters its Spinach® Infused Pre-roll Portfolio with CBG, CBC and CBN
-
Cronos Bolsters its Spinach® Infused Pre-roll Portfolio with CBG, CBC and CBN
-
Cronos Group Reports 2022 Fourth Quarter and Full-Year Results
-
Cronos Group Reports 2022 Fourth Quarter and Full-Year Results
-
Cronos Group Inc. to Hold 2022 Fourth Quarter and Full-Year Earnings Conference Call on February 28, 2023
-
Cronos Group Inc. to Hold 2022 Fourth Quarter and Full-Year Earnings Conference Call on February 28, 2023
-
Spinach® Becomes the Number One Edible Brand in January¹
-
Spinach® Becomes the Number One Edible Brand in January¹
-
Cronos Group Inc. Announces Receipt of Notice of Relinquishment of Warrant by Altria
-
Cronos Group Inc. Announces Receipt of Notice of Relinquishment of Warrant by Altria
-
Cronos Unveils its New CBC Product: Spinach FEELZ™ Day Trip Gummies With THC+CBC
-
Cronos Unveils its New CBC Product: Spinach FEELZ™ Day Trip Gummies With THC+CBC
-
Cronos Group Inc. to Speak at Stifel Canada’s 3rd Annual Future of Healthcare Conference
-
Cronos Group Inc. to Speak at Stifel Canada’s 3rd Annual Future of Healthcare Conference
-
Cronos Group Appoints James Holm as Chief Financial Officer
-
Cronos Group Appoints James Holm as Chief Financial Officer
-
Cronos Group Reports 2022 Third Quarter Results
-
Cronos Group Reports 2022 Third Quarter Results
-
Cronos Group Inc. Announces Final Settlement Agreements
Back to CRON Stock Lookup